NMPA Approval

Moxifloxacin Hydrochloride and Sodium Chloride Injection

Approval Number

国药准字H20243494

Company江苏长江药业有限公司

Registration Date

April 17, 2024

Drug Information

Generic Name

盐酸莫西沙星氯化钠注射液

Dosage Form

注射剂

Strength

250ml：盐酸莫西沙星（按C₂₁H₂₄FN₃O₄计）0.4g与氯化钠2.0g

Drug Type

化学药品

Registration Date

April 17, 2024

Company Information

Applicant Company

Company Name江苏长江药业有限公司

Company Address

射阳县合德镇红旗路28号

Manufacturing Company

Company Name江苏长江药业有限公司

Company Address

江苏射阳县城红旗路28号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

盐酸莫西沙星氯化钠注射液 - NMPA 批准文号 | MedPath